SPRO Smart Money
Spero Therapeutics, Inc.
1W: -3.2%
1M: -2.5%
3M: -45.7%
YTD: -49.4%
1Y: -39.3%
3Y: -0.8%
5Y: -93.7%
$1.19
-0.07 (-5.56%)
Weekly Expected Move ±11.7%
$1
$1
$1
$1
$1
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
🏦 Institutional Activity
Latest: Q2 202673
Institutions Holding
+11 vs prior
69.0%
Ownership
-1.10%
23
New
16
Increased
18
Reduced
12
Closed
👔 Insider Trades
25 records| Date | Name | Title | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2026-08-03 | Zack Debra | officer: chief medical officer | A-Grant/Award | 162,311 | $— | $0 | Filing |
| 2026-06-23 | Deshpande Milind | director | A-Grant/Award | 10,000 | $— | $0 | Filing |
| 2026-06-23 | VINK PATRICK V.J.J. | director | A-Grant/Award | 10,000 | $— | $0 | Filing |
| 2026-06-23 | Smith Cynthia | director | A-Grant/Award | 10,000 | $— | $0 | Filing |
| 2026-06-23 | Tregoning Kathleen | director | A-Grant/Award | 10,000 | $— | $0 | Filing |
| 2026-06-23 | Pottage John C Jr | director | A-Grant/Award | 10,000 | $— | $0 | Filing |
| 2026-06-23 | Jackson Scott Thomas | director | A-Grant/Award | 10,000 | $— | $0 | Filing |
| 2026-06-23 | THOMAS FRANK E | director | A-Grant/Award | 10,000 | $— | $0 | Filing |
| 2026-05-04 | Rajavelu Esther | officer: see remarks | S-Sale | 25,240 | $2.51 | $63K | Filing |
| 2026-02-06 | Rajavelu Esther | officer: see remarks | S-Sale | 50,816 | $2.36 | $120K | Filing |
| 2026-02-06 | Keutzer Timothy | officer: chief operating officer | S-Sale | 18,652 | $2.36 | $44K | Filing |
| 2026-02-06 | Rajavelu Esther | officer: see remarks | S-Sale | 37,101 | $2.36 | $88K | Filing |
| 2026-02-04 | Keutzer Timothy | officer: chief operating officer | S-Sale | 3,471 | $2.24 | $8K | Filing |
| 2026-02-03 | Keutzer Timothy | officer: chief operating officer | S-Sale | 24,224 | $2.14 | $52K | Filing |
| 2026-02-02 | Rajavelu Esther | officer: see remarks | A-Grant/Award | 249,000 | $— | $0 | Filing |
| 2026-02-02 | Rajavelu Esther | officer: see remarks | S-Sale | 18,442 | $2.20 | $41K | Filing |
| 2026-02-02 | Keutzer Timothy | officer: chief operating officer | S-Sale | 18,891 | $2.20 | $42K | Filing |
| 2026-02-02 | Keutzer Timothy | officer: chief operating officer | A-Grant/Award | 68,000 | $— | $0 | Filing |
| 2025-11-07 | Rajavelu Esther | officer: see remarks | S-Sale | 40,270 | $2.37 | $95K | Filing |
| 2025-08-28 | Mahadevia Ankit | director | S-Sale | 6,572 | $1.97 | $13K | Filing |
| 2025-08-28 | Keutzer Timothy | officer: chief operating officer | S-Sale | 1,695 | $1.97 | $3K | Filing |
| 2025-06-12 | THOMAS FRANK E | director | A-Grant/Award | 20,000 | $— | $0 | Filing |
| 2025-06-12 | VINK PATRICK V.J.J. | director | A-Grant/Award | 20,000 | $— | $0 | Filing |
| 2025-06-12 | Pottage John C Jr | director | A-Grant/Award | 20,000 | $— | $0 | Filing |
| 2025-06-12 | Jackson Scott Thomas | director | A-Grant/Award | 20,000 | $— | $0 | Filing |
🏛️ Congressional Trades
0 records| Date | Politician | Chamber | Type | Amount | Filing |
|---|---|---|---|---|---|
| No congressional trades found | |||||
🏦 Top Institutional Holders
20 holders| Holder | Shares | Value | Date Reported | Filing | |
|---|---|---|---|---|---|
| GSK plc | 9,190,606 | $20M | — | 2026-06-30 | Filing |
| Pfizer Inc | 2,362,348 | $5M | — | 2026-06-30 | Filing |
| VANGUARD CAPITAL MANAGEMENT LLC | 2,036,226 | $5M | +236,346 | 2026-06-30 | Filing |
| RENAISSANCE TECHNOLOGIES LLC | 947,904 | $2M | -241,331 | 2026-06-30 | Filing |
| Alphabet Inc. | 889,979 | $2M | — | 2026-06-30 | Filing |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 759,290 | $2M | +426,175 | 2026-06-30 | Filing |
| BlackRock, Inc. | 594,404 | $1M | +161,202 | 2026-06-30 | Filing |
| GEODE CAPITAL MANAGEMENT, LLC | 566,329 | $1M | +46,407 | 2026-06-30 | Filing |
| RAYMOND JAMES FINANCIAL INC | 521,705 | $1M | +521,705 | 2026-06-30 | Filing |
| TWO SIGMA INVESTMENTS, LP | 382,814 | $846K | -502,817 | 2026-06-30 | Filing |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | 332,970 | $736K | +332,970 | 2026-06-30 | Filing |
| VANGUARD FIDUCIARY TRUST CO | 287,648 | $636K | +23,533 | 2026-06-30 | Filing |
| GSA CAPITAL PARTNERS LLP | 285,906 | $632K | +7,602 | 2026-06-30 | Filing |
| DIMENSIONAL FUND ADVISORS LP | 274,820 | $608K | +245,052 | 2026-06-30 | Filing |
| GOLDMAN SACHS GROUP INC | 256,985 | $568K | +256,985 | 2026-06-30 | Filing |
| STATE STREET CORP | 214,751 | $475K | — | 2026-06-30 | Filing |
| JANE STREET GROUP, LLC | 158,097 | $349K | +51,752 | 2026-06-30 | Filing |
| UBS Group AG | 139,680 | $309K | +136,671 | 2026-06-30 | Filing |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 114,800 | $254K | — | 2026-06-30 | Filing |
| NORTHERN TRUST CORP | 108,274 | $239K | -12,710 | 2026-06-30 | Filing |